Business Description
Atreca Inc
NAICS : 325412
SIC : 2834
ISIN : US04965G1094
Share Class Description:
BCEL: Class ADescription
Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. It has single segment business of therapeutic drug discovery and development. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.16 | |||||
| 9-Day RSI | 49.18 | |||||
| 14-Day RSI | 48.56 | |||||
| 6-1 Month Momentum % | -61.22 | |||||
| 12-1 Month Momentum % | -91.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-Forward-EBIT | -0.44 | |||||
| EV-to-Forward-EBITDA | -0.44 | |||||
| EV-to-Forward-Revenue | 9.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BCEL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Atreca Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.5 | ||
| Beta | 0 | ||
| Volatility % | 168.69 | ||
| 14-Day RSI | 48.56 | ||
| 14-Day ATR ($) | 0.010239 | ||
| 20-Day SMA ($) | 0.09068 | ||
| 12-1 Month Momentum % | -91.36 | ||
| 52-Week Range ($) | 0.052 - 1.2 | ||
| Shares Outstanding (Mil) | 39.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Atreca Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Atreca Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Atreca Inc Frequently Asked Questions
What is Atreca Inc(BCEL)'s stock price today?
The current price of BCEL is $0.09. The 52 week high of BCEL is $1.20 and 52 week low is $0.05.
When is next earnings date of Atreca Inc(BCEL)?
The next earnings date of Atreca Inc(BCEL) is 2025-02-14 Est..
Does Atreca Inc(BCEL) pay dividends? If so, how much?
Atreca Inc(BCEL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers